Published in J Pharm Sci on April 04, 2012
A preformulation strategy for the selection of penetration enhancers for a transungual formulation. AAPS PharmSciTech (2013) 0.77
Size and Charge Dependence of Ion Transport in Human Nail Plate. J Pharm Sci (2016) 0.76
Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain. J Control Release (2015) 0.76
Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Mycoses (2017) 0.75
Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm (2007) 2.07
Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm (2007) 1.94
Recent advances in neonatal pharmacotherapy. Ann Pharmacother (2006) 1.38
Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci (2005) 1.16
Melt extrusion with poorly soluble drugs. Int J Pharm (2012) 1.15
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int J Pharm (2007) 1.09
Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery. Mol Pharm (2009) 1.07
Iontophoretic permselective property of human nail. J Dermatol Sci (2007) 0.97
Noninvasive transcutaneous sampling of glucose by electroporation. J Diabetes Sci Technol (2008) 0.95
Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement. Pharm Res (2008) 0.92
Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech (2007) 0.92
Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech (2015) 0.91
Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci (2009) 0.91
Preformulation studies of a prodrug of Delta9-tetrahydrocannabinol. AAPS PharmSciTech (2008) 0.91
Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech (2010) 0.90
Water vapor sorption of hot-melt extruded hydroxypropyl cellulose films: effect on physico-mechanical properties, release characteristics, and stability. J Pharm Sci (2004) 0.89
Ungual and transungual drug delivery. Drug Dev Ind Pharm (2011) 0.89
Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. AAPS PharmSciTech (2012) 0.88
Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion. Drug Dev Ind Pharm (2012) 0.88
The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci (2004) 0.87
Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. J Control Release (2009) 0.86
The use of near-infrared spectroscopy for the quantitation of a drug in hot-melt extruded films. Drug Dev Ind Pharm (2004) 0.86
Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH. AAPS PharmSciTech (2006) 0.86
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique). Int J Pharm (2008) 0.85
Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther (2013) 0.85
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci (2009) 0.85
mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opin Drug Deliv (2014) 0.84
Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology. Pharm Dev Technol (2012) 0.84
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci (2011) 0.84
Polymeric systems for amorphous Delta 9-tetrahydrocannabinol produced by a hot-melt method. Part I: chemical and thermal stability during processing. J Pharm Sci (2006) 0.84
Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm (2009) 0.83
Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv (2010) 0.83
Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol (2009) 0.83
Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm (2006) 0.83
Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives. Int J Pharm (2008) 0.83
In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol (2008) 0.83
Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J (2014) 0.82
Constant voltage 'Iron'tophoresis. Pharm Dev Technol (2010) 0.82
Influence of processing parameters and formulation factors on the bioadhesive, temperature stability and drug release properties of hot-melt extruded films containing miconazole. AAPS PharmSciTech (2014) 0.81
Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design. J Control Release (2010) 0.81
"ChilDrive": a technique of combining regional cutaneous hypothermia with iontophoresis for the delivery of drugs to synovial fluid. Pharm Res (2009) 0.81
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci (2009) 0.81
The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets. J Pharm Sci (2014) 0.80
Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm (2011) 0.80
Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery. Int J Pharm (2010) 0.80
Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices. Eur J Pharm Biopharm (2008) 0.80
Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins. AAPS PharmSciTech (2011) 0.80
Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation. Drug Dev Ind Pharm (2015) 0.79
Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy. J Pharm Sci (2011) 0.79
Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery. AAPS PharmSciTech (2012) 0.79
Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater (2011) 0.79
A study on the effect of inorganic salts in transungual drug delivery of terbinafine. J Pharm Pharmacol (2009) 0.79
Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability. J Pharm Sci (2006) 0.79
Delivery of brain-derived neurotrophic factor via nose-to-brain pathway. Pharm Res (2011) 0.79
Microporation and 'iron'tophoresis for treating iron deficiency anemia. Pharm Res (2012) 0.79
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration. J Drug Target (2012) 0.79
Electroporation and transcutaneous sampling (ETS) of acyclovir. J Dermatol Sci (2007) 0.79
A platform for predicting and enhancing model drug delivery across the human nail plate. Drug Dev Ind Pharm (2010) 0.78
Magnetophoresis in combination with chemical enhancers for transdermal drug delivery. Drug Dev Ind Pharm (2011) 0.78
Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. J Pharm Pharmacol (2013) 0.78
An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res (2009) 0.77
Development and evaluation of a pH-dependent sustained release tablet for irritable bowel syndrome. Drug Dev Ind Pharm (2009) 0.77
Delivery of cefotaxime to the brain via intranasal administration. Drug Dev Ind Pharm (2011) 0.77
Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations. Pharm Res (2013) 0.77
Off-line and on-line measurements of drug-loaded hot-melt extruded films using Raman spectroscopy. Int J Pharm (2008) 0.77
Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opin Drug Deliv (2014) 0.77
Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci (2009) 0.77
Investigation of phase diagrams and physical stability of drug-polymer solid dispersions. Pharm Dev Technol (2014) 0.77
Iontophoretic drug delivery for the treatment of scars. J Pharm Sci (2014) 0.77
Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins. AAPS PharmSciTech (2010) 0.77
Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization. Pharm Dev Technol (2011) 0.77
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv (2010) 0.77
A quality by design approach to understand formulation and process variability in pharmaceutical melt extrusion processes. J Pharm Pharmacol (2015) 0.76
Delivery of itraconazole from extruded HPC films. Drug Dev Ind Pharm (2007) 0.76
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci (2010) 0.76
Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates. AAPS PharmSciTech (2014) 0.76
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil. Pharmazie (2010) 0.76
In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets. Eur J Pharm Biopharm (2007) 0.75
Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium. J Pharm Sci (2014) 0.75
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci (2012) 0.75
Minimally invasive transdermal delivery of iron-dextran. J Pharm Sci (2012) 0.75
Iontophoresis for treating nail diseases. Ther Deliv (2013) 0.75
In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol (2010) 0.75
Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv (2014) 0.75
Albumin microspheres for oral delivery of iron. J Drug Target (2010) 0.75
Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model. Behav Brain Res (2013) 0.75
Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment. J Pharm Sci (2014) 0.75
OcuDrain-E-A noninvasive technique for reduction of intraocular pressure. Int J Pharm (2008) 0.75
Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm (2014) 0.75